Tenpoint Therapeutics Announces United Kingdom Submission of Marketing Authorization Application to the Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Blurry Close-Up Vision (Presbyopia) in Adults
The product, branded YUVEZZI™, received approval from the U.S. Food and Drug Administration (FDA) in January 2026 as…
